組織工学の世界市場レポート 2024年

組織工学の市場規模は近年急速に拡大しています。2023年の133億6,000万米ドルから2024年には153億8,000万米ドルへと、CAGR15.1％で拡大します。歴史的な期間に観察された成長は、バイオマテリアルの著しい進歩、高齢化人口の拡大、慢性疾患の顕著な有病率の増加、再生医療の実践に対する支持的な規制措置、臓器移植に対する患者からの需要の高まりなど、いくつかの要因に主に起因しています。これらの要素は、組織工学および再生医療分野の成長と発展に総体的に寄与しています。

組織工学市場規模は、今後数年で急成長が見込まれます。2028年には年間平均成長率（CAGR）14.4％で263億3,000万米ドルに成長します。予測期間中に予想される成長は、精密医療アプローチの採用、免疫調節技術の重視の高まり、整形外科治療への幅広い応用、この分野への資金調達と投資の増大、慢性疾患の罹患率の増加など、いくつかの重要な要因に起因しています。これらの要因は、組織工学および再生医療において予想される進歩を総体的に促進します。この期間に予想される主な動向には、ナノテクノロジーの方法論への統合、高度な3D細胞培養技術の利用、臓器オンチップ技術の開発と利用、研究と応用における人工知能の統合、革新的な細胞源の探求などが含まれます。これらの動向は、予測期間において組織工学と再生医療実践の進化を形成し、推進する態勢を整えています。

慢性疾患と外傷性救急疾患の有病率の増加が予想され、組織工学市場の成長を促進します。慢性疾患は、3カ月以上続く持続的な臨床状態を特徴とし、多くの場合、決定的な治療法なしに継続的な管理を必要とします。一方、外傷性救急疾患とは、外傷性脳損傷など、緊急の医療処置が必要な突然の重篤な身体的損傷を指します。ヘルスケアの専門家は、慢性疾患や外傷の治療に、自家移植や同種移植、異種移植、人工代替物など、さまざまな技術を用いた組織工学を広く採用しています。例えば、メアリー・アン・リーバート社の2021年3月の報告書によれば、米国全人口の約2％が慢性創傷に罹患しており、一方、2020年には米国疾病予防管理センター（CDC）が米国で約64,000人の外傷性脳損傷を記録し、TBIにより毎日約176人が死亡しています。このことは、蔓延する慢性疾患や外傷による緊急事態に対処する上で、組織工学が重要な役割を果たすことを強調し、組織工学市場の成長を促進しています。

心血管障害の有病率の上昇は、組織工学市場の成長にさらに貢献すると予想されます。心血管疾患は心血管疾患（CVD）としても知られ、心臓や血管に影響を及ぼすさまざまな病状を包含します。組織工学では、損傷を受けた心臓や血管組織を修復・再生するソリューションが開発されており、有望な治療オプションが提供されています。2021年の世界保健機関（WHO）によると、30～69歳の年間1,500万人以上が非感染性疾患（NCDs）で死亡しており、なかでも心血管疾患が最も多く、毎年1,790万人が死亡しています。特に中低所得国でのこのような蔓延は、効果的なソリューションへの需要を強調し、組織工学市場の成長をさらに後押ししています。組織工学市場の拡大は、慢性疾患から外傷性救急疾患、心臓血管障害に至るまで、さまざまな病状に対応する役割によって強調されています。

2023年の組織工学市場で最大の地域は北米でした。アジア太平洋は、予測期間中に組織工学市場で最も急成長する地域と予想されています。組織工学市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 組織工学市場の特徴

第3章 組織工学市場の動向と戦略

第4章 組織工学市場- マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の組織工学市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 組織工学市場セグメンテーション

• 世界の組織工学市場、タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 合成足場材料
• 生物由来足場材料
• その他のタイプ
• 世界の組織工学市場、用途別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 整形外科と筋骨格系
• 神経内科
• 心臓血管
• 皮膚と外皮
• 歯科
• その他の用途
• 世界の組織工学市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 病院と診療所
• 外来施設

第7章 組織工学市場の地域および国分析

• 世界の組織工学市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の組織工学市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋組織工学市場

第9章 中国組織工学市場

第10章 インドの組織工学市場

第11章 日本の組織工学市場

第12章 オーストラリアの組織工学市場

第13章 インドネシアの組織工学市場

第14章 韓国の組織工学市場

第15章 西欧の組織工学市場

第16章 英国の組織工学市場

第17章 ドイツの組織工学市場

第18章 フランスの組織工学市場

第19章 イタリアの組織工学市場

第20章 スペインの組織工学市場

第21章 東欧の組織工学市場

第22章 ロシアの組織工学市場

第23章 北米組織工学市場

第24章 米国組織工学市場

第25章 カナダの組織工学市場

第26章 南米組織工学市場

第27章 ブラジルの組織工学市場

第28章 中東組織工学市場

第29章 アフリカ組織工学市場

第30章 組織工学市場の競合情勢と企業プロファイル

• 組織工学市場の競合情勢
• 組織工学市場の企業プロファイル
  • Medtronic plc
  • Zimmer Biomet
  • Allergan plc
  • Organogenesis Holdings Inc.
  • Integra LifeSciences

第31章 世界の組織工学市場の競合ベンチマーキング

第32章 世界の組織工学市場競争ダッシュボード

第33章 組織工学市場における主要な合併と買収

第34章 組織工学市場の将来展望と可能性分析

第35章 付録

“Tissue Engineering Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tissue engineering market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tissue engineering? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The tissue engineering market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Type: Synthetic Scaffold Material; Biologically Derived Scaffold Material; Other Types
• 2) By Application: Orthopedics And Musculoskeletal; Neurology; Cardiovascular; Skin And Integumentary; Dental; Other Applications;;
• 3) By End-User: Hospitals And Clinics; Ambulatory Facilities
• Companies Mentioned: Medtronic plc; Zimmer Biomet; Allergan plc; Organogenesis Holdings Inc.; Integra LifeSciences
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Tissue engineering is a specialized field within biomedical engineering that combines biological and engineering methodologies. It aims to generate three-dimensional tissue and cellular products both in vivo (within a living organism) and in vitro (outside a living organism) by modifying cell growth conditions and utilizing appropriate cell isolates from donor tissues alongside biocompatible scaffold materials. The primary objective is to restore, repair, maintain, or enhance tissue function by replacing or regenerating damaged tissues, thereby improving human body functions.

Key categories within tissue engineering encompass synthetic scaffold materials, biologically derived scaffold materials, and other methodologies. Synthetic scaffold materials are synthetic polymers composed of fibrous proteins that simulate an extracellular matrix, promoting favorable cellular responses and behaviors in tissue engineering applications. These materials find diverse applications across orthopedics and musculoskeletal treatments, neurology, cardiovascular procedures, skin and integumentary therapies, dental applications, among others. Various end-users including hospitals, clinics, and ambulatory facilities utilize these materials for their respective medical applications.

The tissue engineering market research report is one of a series of new reports from The Business Research Company that provides tissue engineering market statistics, including the tissue engineering industry global market size, regional shares, competitors with a tissue engineering market share, detailed tissue engineering market segments, market trends and opportunities, and any further data you may need to thrive in the tissue engineering industry. This tissue engineering market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tissue engineering market size has grown rapidly in recent years. It will grow from $13.36 billion in 2023 to $15.38 billion in 2024 at a compound annual growth rate (CAGR) of 15.1%. The growth observed in the historic period can be primarily attributed to several factors, including significant advancements in biomaterials, the expanding aging population demographic, a notable increase in the prevalence of chronic diseases, supportive regulatory measures for regenerative medicine practices, and a rising demand from patients for organ transplants. These elements collectively contributed to the growth and development within the field of tissue engineering and regenerative medicine.

The tissue engineering market size is expected to see rapid growth in the next few years. It will grow to $26.33 billion in 2028 at a compound annual growth rate (CAGR) of 14.4%. The anticipated growth in the forecast period can be attributed to several key factors, including the adoption of precision medicine approaches, a heightened emphasis on immunomodulation techniques, broader applications within orthopedic treatments, augmented funding and investment in the field, and a growing incidence of chronic diseases. These factors collectively drive the anticipated advancements within tissue engineering and regenerative medicine. Major trends expected during this period encompass the integration of nanotechnology into methodologies, the utilization of advanced 3D cell culture techniques, the development and utilization of organ-on-a-chip technology, the integration of artificial intelligence in research and applications, and the exploration of innovative cell sources. These trends are poised to shape and drive the evolution of tissue engineering and regenerative medicine practices in the forecasted period.

The anticipated increase in the prevalence of chronic diseases and trauma emergencies is poised to drive the growth of the tissue engineering market. Chronic diseases are characterized by enduring clinical conditions that persist for three months or longer, often requiring ongoing management without definitive cures. Conversely, trauma emergencies refer to sudden and severe physical injuries necessitating immediate medical attention, such as traumatic brain injuries. Healthcare professionals widely adopt tissue engineering for treating chronic disorders and trauma, employing various techniques such as autologous or allograft transplantation, xenotransplantation, and artificial substitutes. For example, a March 2021 report from Mary Ann Liebert, Inc. indicated that approximately 2% of the total U.S. population is affected by chronic wounds, while in 2020, the Centers for Disease Control and Prevention (CDC) recorded around 64,000 traumatic brain injuries in the United States, resulting in approximately 176 deaths daily due to TBI. This underscores the critical role of tissue engineering in addressing prevalent chronic diseases and trauma emergencies, driving the growth of the tissue engineering market.

The rising prevalence of cardiovascular disorders is expected to further contribute to the growth of the tissue engineering market. Cardiovascular disorders, also known as cardiovascular diseases (CVD), encompass various medical conditions affecting the heart and blood vessels. In tissue engineering, solutions are developed to repair and regenerate damaged cardiac and vascular tissues, offering promising treatment options. According to the World Health Organization in 2021, more than 15 million people aged 30 to 69 die annually from non-communicable diseases (NCDs), with cardiovascular disease being the most common, causing 17.9 million deaths each year. This prevalence, particularly in low- and middle-income countries, emphasizes the demand for effective solutions, further driving the growth of the tissue engineering market. The tissue engineering market's expansion is underscored by its role in addressing a spectrum of medical conditions, from chronic diseases to trauma emergencies and cardiovascular disorders.

Technological advancement stands out as a prominent trend gaining momentum in the tissue engineering market. Major companies within the industry are placing a significant focus on research and development to drive product innovations, providing enhanced solutions and solidifying their market positions. An example of this commitment is CELLINK, a U.S.-based company specializing in tissue engineering, which introduced its advanced bioprinter in March 2021. The BIO MDX Series, operating on 3D bioprinting technology, utilizes bio-inks and living cells to construct natural 3D tissue structures. This innovative technology comprises printheads, nanoliter and picoliter dispensing channels, and robotic integration, enabling precision bioprinting for high-throughput fabrication. The utilization of advanced bioprinting technologies reflects the industry's dedication to pushing the boundaries of tissue engineering for improved outcomes in cell-based technologies.

Major companies are strategically engaging in partnerships and collaborations with start-ups and mid-sized companies to expand their product and service offerings in the tissue engineering market. These collaborative efforts play a crucial role in broadening companies' product portfolios and extending their geographical reach. An illustrative instance is the collaboration agreement between Regen Lab, a Swiss-based medical technology company specializing in tissue engineering, Long Island University (LIU), and the Dassault Systemes Group (3DS) in June 2023. Under this agreement, LIU and RegenLab USA join forces to establish an industrial innovation accelerator, a new center of excellence dedicated to regenerative medicine and tissue engineering. Such strategic collaborations enhance the capabilities and offerings of companies in the tissue engineering market, fostering innovation and growth. LIU, based in the U.S., and Dassault Systemes Group, a French software corporation, are key partners in this initiative.

In October 2022, Geistlich Pharma, a US-based company specializing in bone, cartilage, and tissue regeneration, completed the acquisition of Lynch Biologics, LLC. The financial specifics of this acquisition were not disclosed. This strategic move serves to bolster Geistlich's existing regenerative product portfolio and augments its growth prospects within the field. Lynch Biologics, the acquired company, is also based in the US and is known for its focus on regenerative medicine and tissue engineering. They specialize in supplying advanced biotechnology products aimed at fostering healing and tissue regeneration.

Major companies operating in the tissue engineering market report are Medtronic plc, Zimmer Biomet, Allergan plc, Organogenesis Holdings Inc., Integra LifeSciences, Stryker Corporation, DePuy Synthes Companies, Acelity L.P. Inc., B. Braun Melsungen AG, RTI Surgical Inc., AbbVie Inc., Becton Dickinson and Company, Baxter International Inc., Osiris Therapeutics Inc., Organovo Inc., BioTime Inc., Bio Tissue Technologies, Vericel Corporation, Smith and Nephew, Acell Inc., Athersys Inc., Tissue Regenix Group plc, Xeltis AG, Prellis Biologics, Butterfly Network Inc., iThera Medical GmbH, Bit Bio, Be Biopharma Inc., The Takeda Pharmaceutical Company, Frequency Therapeutics, TELA Bio Inc., Orthocell Limited .

North America was the largest region in the tissue engineering market in 2023. Asia-Pacific is expected to be the fastest-growing region in the tissue engineering market during the forecast period. The regions covered in the tissue engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the tissue engineering market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tissue engineering market consists of sales of reparative cells, bioreactive molecules, such as cytokines, growth factors, biomaterials, and bioreactors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Tissue Engineering Market Characteristics

3. Tissue Engineering Market Trends And Strategies

4. Tissue Engineering Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Tissue Engineering Market Size and Growth

• 5.1. Global Tissue Engineering Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Tissue Engineering Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Tissue Engineering Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Tissue Engineering Market Segmentation

• 6.1. Global Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Synthetic Scaffold Material
• Biologically Derived Scaffold Material
• Other Types
• 6.2. Global Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Orthopedics And Musculoskeletal
• Neurology
• Cardiovascular
• Skin And Integumentary
• Dental
• Other Applications
• 6.3. Global Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals And Clinics
• Ambulatory Facilities

7. Tissue Engineering Market Regional And Country Analysis

• 7.1. Global Tissue Engineering Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Tissue Engineering Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Tissue Engineering Market

• 8.1. Asia-Pacific Tissue Engineering Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Tissue Engineering Market

• 9.1. China Tissue Engineering Market Overview
• 9.2. China Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Tissue Engineering Market

• 10.1. India Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Tissue Engineering Market

• 11.1. Japan Tissue Engineering Market Overview
• 11.2. Japan Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Tissue Engineering Market

• 12.1. Australia Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Tissue Engineering Market

• 13.1. Indonesia Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Tissue Engineering Market

• 14.1. South Korea Tissue Engineering Market Overview
• 14.2. South Korea Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Tissue Engineering Market

• 15.1. Western Europe Tissue Engineering Market Overview
• 15.2. Western Europe Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Tissue Engineering Market

• 16.1. UK Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Tissue Engineering Market

• 17.1. Germany Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Tissue Engineering Market

• 18.1. France Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Tissue Engineering Market

• 19.1. Italy Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Tissue Engineering Market

• 20.1. Spain Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Tissue Engineering Market

• 21.1. Eastern Europe Tissue Engineering Market Overview
• 21.2. Eastern Europe Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Tissue Engineering Market

• 22.1. Russia Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Tissue Engineering Market

• 23.1. North America Tissue Engineering Market Overview
• 23.2. North America Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Tissue Engineering Market

• 24.1. USA Tissue Engineering Market Overview
• 24.2. USA Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Tissue Engineering Market

• 25.1. Canada Tissue Engineering Market Overview
• 25.2. Canada Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Tissue Engineering Market

• 26.1. South America Tissue Engineering Market Overview
• 26.2. South America Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Tissue Engineering Market

• 27.1. Brazil Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Tissue Engineering Market

• 28.1. Middle East Tissue Engineering Market Overview
• 28.2. Middle East Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Tissue Engineering Market

• 29.1. Africa Tissue Engineering Market Overview
• 29.2. Africa Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Tissue Engineering Market Competitive Landscape And Company Profiles

• 30.1. Tissue Engineering Market Competitive Landscape
• 30.2. Tissue Engineering Market Company Profiles
  • 30.2.1. Medtronic plc
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Zimmer Biomet
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Allergan plc
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Organogenesis Holdings Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Integra LifeSciences
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Tissue Engineering Market Competitive Benchmarking

32. Global Tissue Engineering Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Tissue Engineering Market

34. Tissue Engineering Market Future Outlook and Potential Analysis

• 34.1 Tissue Engineering Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Tissue Engineering Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Tissue Engineering Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer